2020
DOI: 10.20892/j.issn.2095-3941.2019.0363
|View full text |Cite
|
Sign up to set email alerts
|

Clinical-pathological and molecular characterization of long-term survivors with advanced non-small cell lung cancer

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

1
6
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8
1

Relationship

0
9

Authors

Journals

citations
Cited by 12 publications
(7 citation statements)
references
References 45 publications
1
6
0
Order By: Relevance
“…Three genes ( SFTPB , WFDC2 , and HLA-DQA1 ) were associated with reduced prognostic risk, while the other six genes ( HLA-DPA1 , TIMP1 , MS4A7 , VCAN , KRT8 , and FABP5 ) were predictors of unfavorable survival. Consistently, in previous studies, a high expression of TIMP1 ( 54 , 55 ), VCAN , KRT8 ( 56 58 ), and FABP5 ( 59 ) and a low expression of SFTPB ( 60 , 61 ), WFDC2 ( 62 , 63 ), and HLA-DQA1 ( 64 , 65 ) were associated with poor prognosis in multiple cancer types. However, a reduced expression of HLA-DPA1 ( 64 , 65 ) and MS4A7 ( 66 ) was reported to be associated with disease progression and unfavorable survival, which differed from the findings in the studies.…”
Section: Discussionsupporting
confidence: 89%
“…Three genes ( SFTPB , WFDC2 , and HLA-DQA1 ) were associated with reduced prognostic risk, while the other six genes ( HLA-DPA1 , TIMP1 , MS4A7 , VCAN , KRT8 , and FABP5 ) were predictors of unfavorable survival. Consistently, in previous studies, a high expression of TIMP1 ( 54 , 55 ), VCAN , KRT8 ( 56 58 ), and FABP5 ( 59 ) and a low expression of SFTPB ( 60 , 61 ), WFDC2 ( 62 , 63 ), and HLA-DQA1 ( 64 , 65 ) were associated with poor prognosis in multiple cancer types. However, a reduced expression of HLA-DPA1 ( 64 , 65 ) and MS4A7 ( 66 ) was reported to be associated with disease progression and unfavorable survival, which differed from the findings in the studies.…”
Section: Discussionsupporting
confidence: 89%
“…The 3 most prominent symptoms in females were associated with AABs to DBT and ROS1. Interestingly, AABs to DBT have been associated with lung cancer [ 26 ]. Importantly, a number of AABs can be classified as implicated more frequently with systemic disease traits (i.e., multi-organ or multi-system) which may be particularly relevant to the more non-specific symptoms such as fatigue, fever, rashes, cold or allergy-type symptoms, weight loss, and muscular weakness.…”
Section: Discussionmentioning
confidence: 99%
“…SFTPC encodes the pulmonary-associated surfactant protein C, a hydrophobic surfactant protein for maintaining stable pulmonary tissue. Moreno-Rubio et al [37] reported the overexpression of SFTPC in long-term survival NSCLC patients, while a Norwegian group reported similar findings. They found that SFTPC and SFTPA mRNAs could be potential markers in regional nodes and peripheral blood in lung cancer [38].…”
Section: Discussionmentioning
confidence: 78%